This study will compare Cognitive Behavioral Social Skills Training-Compensatory Cognitive Training (CBSST-CCT) to a goal-focused supportive contact group to see which intervention better improves symptoms and functioning in people with schizophrenia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
64
UCSD
La Jolla, California, United States
Clinical Assessment Interview for Negative Symptoms (CAINS)
Change in negative symptom severity at 12.5 weeks. Scores range from 0-52; higher values indicate greater severity.
Time frame: baseline, 12.5 weeks
MATRICS Consensus Cognitive Battery (MCCB)
Change in cognitive performance in several domains at 12.5 weeks. Scores range from 0-80; higher scores indicate better performance.
Time frame: baseline, 12.5 weeks
UCSD Performance-based Skills Assessment-Brief (UPSA-B)
Change in communication and financial functioning at 12.5 weeks. Scores range from 0-100; higher scores indicate better performance.
Time frame: baseline, 12.5 weeks
Social Skills Performance Assessment (SSPA)
Change in social skills performance at 12.5 weeks. Scores range from 2-10; higher scores indicate better social skills.
Time frame: baseline, 12.5 weeks
Specific Levels of Functioning Scale (SLOF)
Change in self-reported functioning at 12.5 weeks. Scores range from 30-150. Higher score indicates better functioning.
Time frame: baseline, 12.5 weeks
Independent Living Skills Survey (ILSS)
Change in self-reported functioning at 12.5 weeks. Scores range from 0-1; higher score indicates better skills.
Time frame: baseline, 12.5 weeks
Defeatist Performance Attitudes Scale (DPAS)
Change in defeatist attitudes at 12.5 weeks. Likert Scale 1-7; scores range from 15-105; higher scores indicate a more severe defeatist performance attitude.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: baseline, 12.5 weeks
Scale for the Assessment of Negative Symptoms (SANS)
Change in negative symptom severity at 12.5 weeks. Scores range from 0-25; higher values indicate greater severity.
Time frame: baseline, 12.5 weeks